Hormel (HRL) Stock Looks Reasonably Priced As Earnings Stay Steady

Hormel Foods has seen its share price slide over the past few years, and that drop puts a spotlight on a simple question for investors who focus on fundamentals. Is the current valuation of Hormel stock still in line with the earnings power the business is producing today?

  • Over the past 5 years, the share price has fallen 40.4%, which puts pressure on the question of whether the current valuation fairly reflects Hormel’s earnings profile.

  • The group relies heavily on steady branded food earnings, so any shift in input costs or pricing power can reshape how much value investors choose to ascribe to each dollar of profit.

  • There is a second opinion on Hormel Foods worth weighing. See what analysts think Hormel Foods’s shares could be worth.

The issue now is whether Hormel Foods’ current share price is justified by the earnings it is generating today and what investors expect it to deliver in the future.

If you want a broader context for Hormel Foods’ recent share price slide and current earnings focus, a good next step is to compare it against 27 high quality undervalued stocks.

Does Hormel Foods Look Fairly Valued on Earnings?

The P/E ratio suits Hormel Foods because earnings remain the main anchor for how investors judge this kind of branded food group. Hormel trades on a P/E of 33.8x, which sits well above the wider Food industry average of 18.6x and also above the broader peer group at 22.0x. That is a rich headline number for a company built around steady, mature product lines rather than early stage concepts.

The fair P/E implied by the model, which blends Hormel Foods’ margins, growth outlook, size and business risk, points to a level reasonably close to where the stock trades now. The current 33.8x sits slightly below that tailored reference point, so the market is not paying a dramatic premium over what this framework suggests. For any holder, the key question is whether Hormel can keep converting its brand strength into reliable earnings that justify a mid 30s P/E over time. Explore the numbers behind Hormel Foods’s P/E valuation.

NYSE:HRL P/E Ratio as at Oct 2026
NYSE:HRL P/E Ratio as at Oct 2026

The Hormel Foods Narrative: What Would Justify Today’s Price?

Simply Wall St Narratives for Hormel Foods pick up where the P/E puzzle leaves off. They spell out which future paths for earnings, margins and growth would need to play out for the stock to be worth meaningfully more or less than today’s price on the market. Rather than focusing on a single valuation output, each narrative lays out its own set of embedded assumptions so you can compare those expectations with Hormel Foods’ actual results as they are reported.

One of the top community narratives on Hormel Foods: 17% undervalued

“The ongoing simplification of Hormel Foods’ portfolio, including exits from whole bird turkey, Brazil operations, a majority stake in Justin’s, private label snack nuts and certain contract manufacturing, is removing roughly US$300m of lower margin and more volatile annual sales.”

Discover why this Narrative puts Hormel Foods at 17% undervalued.

The price of Hormel Foods stock is only one piece of the decision

Cash flows and multiples tell you what the market pays for Hormel Foods today, but the people steering the business and the way they are rewarded can heavily influence what happens next. See who runs Hormel Foods and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include HRL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Source link

Visited 1 times, 1 visit(s) today

Related Article

Memory Stocks Are Plummetting. Jensen Huang Says the Bears Have It Wrong.

The AI trade has looked awfully shaky over the last couple of weeks. CoreWeave, the neocloud company that may have more leveraged exposure to AI than any other company due to its massive debt burden, has plunged in recent weeks on fears over its rising debt yields. Missed AI’s “Act 1”? Act 2 Could Be

Arrowhead Pharmaceuticals And 2 Biotech Stocks To Own

Biotech stocks live and die on access to capital, so the Federal Reserve’s signal that interest rates may pause for now gives this high risk corner of the market some breathing room. Cheaper money can make it easier to fund drug pipelines and clinical trials, which matters if you are hunting for the next breakthrough.

Why AT&T Stock Plunged on Friday

Shares of AT&T (NYSE:T) fell 8% on Friday after a new report stoked investors’ fears of a potentially disruptive encroachment by Space Exploration Technologies (NASDAQ:SPCX) into the lucrative U.S. wireless market. Image source: Getty Images. Missed AI’s “Act 1”? Act 2 Could Be 14x Bigger. Most investors think they missed the AI boat because they

Kulicke and Soffa (KLIC): buy, sell, or hold post Q2 earnings?

Kulicke and Soffa (KLIC): buy, sell, or hold post Q2 earnings? Over the past six months, Kulicke and Soffa’s stock price fell to $72.89. Shareholders have lost 13.9% of their capital, which is disappointing considering the S&P 500 has climbed by 9.1%. This may have investors wondering how to approach the situation. Is now the

Why RingCentral Stock Is Up Today

Shares of RingCentral (NYSE:RNG) rose 5% on Friday after the communications software provider raised its full-year free cash flow forecast. Image source: Getty Images. Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a “Double Down” signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same

AT&T Stock Sinks on Subscriber and SpaceX Worries. Is the Stock a Buy on the Dip?

AT&T (T -7.96%) stock had been on a roll, more than doubling from July 2023 to a closing high of $28.10 on March 27, 2026. However, after a strong start to 2026, AT&T stock has since come under pressure from the potential threat of Space Exploration Technologies (SPCX +1.89%) entering the U.S. mobile market. While

The AI sell-off is crushing stocks of companies leading the data center build-out

Two of the AI building boom’s biggest suppliers just posted blowout quarters. Wall Street is dumping them anyway. Bloom Energy (BE), whose fuel cells generate power on-site at data centers, said Thursday that sales jumped 138% last quarter and raised its full-year outlook to roughly 122% growth. Comfort Systems (FIX), which installs the cooling and

Bloom Energy Stock Sinks Despite Record Revenue and a Stellar Outlook. Is It Time to Buy?

Bloom Energy (NYSE:BE) delivered another blowout quarter, smashing estimates and growing profits faster than sales. Yet, its stock plunged after earnings and was down more than 12% as of Friday noon. The company sells solid-oxide fuel cell servers that turn natural gas into electricity right at a customer’s site. Artificial intelligence (AI) data centers desperately

Moderna trims losses as investors digest melanoma vaccine trial data

Moderna (MRNA) trimmed losses Friday, rebounding from a sharp sell-off in the previous session, as investors digested data from a late-stage trial of its personalized melanoma vaccine. The stock opened lower but climbed into positive territory during the session, a day after plunging more than 17% on Thursday in its worst single-day performance since Aug.

Cathie Wood Makes Surprise Move Across Three Popular Tech Stocks

This article first appeared on GuruFocus. Cathie Wood’s ARK Invest bought heavily into Meta Platforms (NASDAQ:META) after the stock’s post-earnings selloff, while reducing exposure to Palantir (NASDAQ:PLTR) and Roblox (RBLX). ARK funds purchased 38,110 Meta shares worth about $24.7 million on Thursday, Oct. 22, after the stock plunged roughly 7% and erased its gains for

Could a $10,000 Investment in Micron Set You Up for Life?

Some companies don’t keep their ambitions secret. They swagger onto the stock market and draw plenty of attention with a splashy IPO and big promises (lookin’ at you, Tesla). But some incredibly successful stocks are sleeper hits: They quietly sit on the market doing nothing until one day, bam! Their shares take off like a

Is Cognex Stock’s Market Price Justified?

For questions about this article or underlying research, email help@trefis.com. Cognex (CGNX) stock trades at 52.3 times its earnings over the last twelve months. That multiple is more than twice the 23.0 times for the S&P 500. Buyers at that price are paying today for profit the machine vision company has not yet earned, while

Prediction: Intel Stock Will Take Off After Oct. 29

After rising incredibly in the first half of 2026, Intel (NASDAQ:INTC) stock has run into rough weather in recent months. Shares of the semiconductor specialist are down by 31% since the beginning of July. However, Intel stock could get a nice shot in the arm following the release of its third-quarter results on Oct. 29.

If a Stock Market Crash Is on the Way, Warren Buffett Says This Is the Best Thing Investors Can Do for Their Portfolio

The S&P 500 (^GSPC -1.21%) and Nasdaq Composite (^IXIC -2.60%) have recently been experiencing a bout of volatility after repeatedly notching record highs throughout 2026. With stocks coming under pressure, some investors are wondering whether a larger market correction is approaching. Part of the concern stems from elevated bond yields and stubborn inflation. Meanwhile, artificial

Adient (ADNT) Stock Sees Modest Fair Value Cut As Analysts Trim Expectations

Adient’s updated analysis now points to a slightly lower modeled fair value, with the price target moving from US$29.55 to US$27.64. This shift sits alongside a split in analyst opinion, where some recently trimmed targets but still argue the stock could re-rate if execution, margins, and capital allocation improve. As you read on, you will

0
Would love your thoughts, please comment.x
()
x